Resistance to alkylating anticancer drugs: Role of the Nrf2-antioxidant system

Sarala Manandhar; Jeong-Min Cho; Hyun-Min Park; Mi-Kyoung Kwak

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

Experimental and Molecular Therapeutics

Resistance to alkylating anticancer drugs: Role of the Nrf2-antioxidant system

Sarala Manandhar, Jeong-Min Cho, Hyun-Min Park and Mi-Kyoung Kwak

Sarala Manandhar

Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, Republic of Korea

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeong-Min Cho

Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, Republic of Korea

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hyun-Min Park

Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, Republic of Korea

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mi-Kyoung Kwak

Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, Republic of Korea

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: Published May 2008

Article
Info & Metrics

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: November 2014 to January 2021

	Abstract	Full-text HTML	PDF
Total	95	0	0

Cited By

Article Information

Volume 68, Issue 9 Supplement, pp. 705

Published By

American Association for Cancer Research

Print ISSN

0008-5472

Online ISSN

1538-7445

American Association for Cancer Research

Author Information

Sarala Manandhar,
Jeong-Min Cho,
Hyun-Min Park, and
Mi-Kyoung Kwak

Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, Republic of Korea

May 2008
Volume 68, Issue 9 Supplement

Table of Contents

Search for this keyword

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Resistance to alkylating anticancer drugs: Role of the Nrf2-antioxidant system

Message Subject (Your Name) has forwarded a page to you from Cancer Research

Message Body (Your Name) thought you would be interested in this article in Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Resistance to alkylating anticancer drugs: Role of the Nrf2-antioxidant system

Sarala Manandhar, Jeong-Min Cho, Hyun-Min Park and Mi-Kyoung Kwak

Cancer Res May 1 2008 (68) (9 Supplement) 705;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Resistance to alkylating anticancer drugs: Role of the Nrf2-antioxidant system

Sarala Manandhar, Jeong-Min Cho, Hyun-Min Park and Mi-Kyoung Kwak

Cancer Res May 1 2008 (68) (9 Supplement) 705;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics

Cited By...

Experimental and Molecular Therapeutics

Abstract 6237: Bone-targeted nanoparticle containing protein therapeutics as an effective delivery system for bone metastasis
Abstract 2932: CD59 facilitates tumor progression through activating TGF-β/Smad signaling pathway in hepatocellular carcinoma
Abstract 6378: CDC20 is a novel therapeutic target in triple-negative breast cancer

Show more Experimental and Molecular Therapeutics

Drug Resistance 2: Platinum Agents and Taxanes: Poster Presentations - Proffered Abstracts

Targeting glucosylceramide synthase reverses drug resistance through ceramide- induced apoptosis in vivo
Molecular mechanisms of patupilone resistance
The resistance to taxanes of brca2 associated breast cancer

Show more Drug Resistance 2: Platinum Agents and Taxanes: Poster Presentations - Proffered Abstracts

Home
Alerts
Feedback
Privacy Policy

Articles

Online First
Current Issue
Past Issues
Meeting Abstracts

Info for

Authors
Subscribers
Advertisers
Librarians

About Cancer Research

About the Journal
Editorial Board
Permissions
Submit a Manuscript

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Main menu

User menu

Search

Resistance to alkylating anticancer drugs: Role of the Nrf2-antioxidant system

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: November 2014 to January 2021

Cited By

Article Information

Author Information

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Experimental and Molecular Therapeutics

Drug Resistance 2: Platinum Agents and Taxanes: Poster Presentations - Proffered Abstracts

Articles

Info for

About Cancer Research